Citron kinase activity controls alternative splicing events that drive prostate cancer growth
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Thus, CIT-mediated alternative splicing drives CaP progression, and its inhibition is a new therapeutic strategy in treatment-resistant CaP.
Appeared: Sunday, October 11. Science Advances. Peer-reviewed journal.